UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis

European journal of public health, 2016-10, Vol.26 (5), p.804-813

2016

Volltextzugriff (PDF)

Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer's disease

Scientific reports, 2020-01, Vol.10 (1), p.1346-1346, Article 1346

2020

Volltextzugriff (PDF)

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

Diabetologia, 2020-12, Vol.63 (12), p.2582-2594

2020

Volltextzugriff (PDF)

Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia

Neurobiology of stress, 2016-12, Vol.5 (C), p.8-18

2016

Volltextzugriff (PDF)

Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equations

PloS one, 2014-10, Vol.9 (10), p.e110235-e110235

2014

Volltextzugriff (PDF)

The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and App NL−F/NL−F mice

Alzheimer's research & therapy, 2024, Vol.16 (1), p.1-12

2024

Volltextzugriff (PDF)

Treatment Preferences for Acute Allergic Reactions: A Discrete Choice Experiment

Journal of health economics and outcomes research (Online), 2024-06, Vol.11 (1), p.157-165

2024

Volltextzugriff (PDF)

Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease

Alzheimer's research & therapy, 2019-10, Vol.11 (1), p.87-87, Article 87

2019

Volltextzugriff (PDF)

Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease

Alzheimer's research & therapy, 2023-03, Vol.15 (1), p.1-13

2023

Volltextzugriff (PDF)

Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden

BMC urology, 2024-07, Vol.24 (1), p.1-12, Article 148

2024

Volltextzugriff (PDF)

Disease burden and unmet need for acute allergic reactions – A patient perspective

The World Allergy Organization journal, 2024-04, Vol.17 (4), p.100896-100896, Article 100896

2024

Volltextzugriff (PDF)

Prevalence of antibodies against Toxoplasma gondii and Neospora spp. in equids of Western Pará, Brazil

Acta tropica, 2019-01, Vol.189, p.39-45

2019

Volltextzugriff (PDF)

Analgesic efficacy of sleep-promoting pharmacotherapy in patients with chronic pain: a systematic review and meta-analysis

Pain reports, 2023-01, Vol.8 (1), p.e1061-e1061

2023

Volltextzugriff (PDF)

The App NL‐G‐F /MAPT mouse model of Alzheimer’s Disease demonstrates increased levels of ptau217 in CSF, changes that correlate with increased cerebral p‐tau depositions

Alzheimer's & dementia, 2023-12, Vol.19 (S12)

2023

Volltextzugriff (PDF)

The AppNL‐G‐F/MAPT mouse model of Alzheimer’s Disease demonstrates increased levels of ptau217 in CSF, changes that correlate with increased cerebral p‐tau depositions

Alzheimer's & dementia, 2023-12, Vol.19, p.n/a

2023

Volltextzugriff (PDF)

The App NL‐F mouse model of Alzheimer’s Disease demonstrates reduced serum Aß42 levels and Aß42/Aß40 ratio, changes that correlate with CSF Aß levels and cerebral Aß42 plaque load

Alzheimer's & dementia, 2022-12, Vol.18 (S4), p.n/a

2022

Volltextzugriff (PDF)

CSF Aβ42 and Aβ40 and their relation to brain soluble and insoluble Aβ in the 5xFAD mouse model of Alzheimer’s disease

Alzheimer's & dementia, 2021-12, Vol.17, p.e055684-n/a

2021

Volltextzugriff (PDF)

Risk sharing in managed entry agreements—A review of the Swedish experience

Health policy (Amsterdam), 2020-04, Vol.124 (4), p.404-410

2020

Volltextzugriff (PDF)

Galectin-3 ablation does not affect infarct size or inflammatory cytokines after experimental stroke in 24-month-old female mice

Neuroreport, 2022-04, Vol.33 (6), p.266

2022

Volltextzugriff (PDF)

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease

Neurobiology of aging, 2020-11, Vol.95, p.143-153

2020

Volltextzugriff (PDF)

Reduced CSF Aβ42 and Aβ42/Aβ40 ratio during early cerebral amyloid deposition in the App NL‐F knock‐in mouse model of Alzheimer’s disease

Alzheimer's & dementia, 2022-12, Vol.18 (S3), p.n/a

2022

Volltextzugriff (PDF)

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease

Science advances, 2020-04, Vol.6 (16), p.eaaz2387-eaaz2387

2020

Volltextzugriff (PDF)

Model‐based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease

Diabetes, obesity & metabolism, 2023-03, Vol.25 (3), p.748-757

2023

Volltextzugriff (PDF)

Current and future costs of obesity in Sweden

Health policy (Amsterdam), 2022-06, Vol.126 (6), p.558-564

2022

Volltextzugriff (PDF)

The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and <i>App</i><SUP>NL-F/NL-F</SUP> mice

Alzheimer's research & therapy, 2024, Vol.16 (1)

2024

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(64)
Medicin Och Hälsovetenskap
(45)
Humans
(30)
Medical And Health Sciences
(30)
Clinical Medicine
(21)
Klinisk Medicin
(21)
Female
(19)
Male
(17)
Social Sciences
(16)
Animals
(15)
Neurosciences
(14)
Science & Technology - Other Topics
(13)
Sweden
(13)
Multidisciplinary Sciences
(12)
Adult
(10)
Health Aspects
(10)
Neurovetenskaper
(10)
Diabetes
(9)
Diabetes Mellitus
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis

Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer's disease

Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden

Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia

Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equations

The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and App NL−F/NL−F mice

Treatment Preferences for Acute Allergic Reactions: A Discrete Choice Experiment

Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease

Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease

Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden

Disease burden and unmet need for acute allergic reactions – A patient perspective

Prevalence of antibodies against Toxoplasma gondii and Neospora spp. in equids of Western Pará, Brazil

Analgesic efficacy of sleep-promoting pharmacotherapy in patients with chronic pain: a systematic review and meta-analysis

The App NL‐G‐F /MAPT mouse model of Alzheimer’s Disease demonstrates increased levels of ptau217 in CSF, changes that correlate with increased cerebral p‐tau depositions

The AppNL‐G‐F/MAPT mouse model of Alzheimer’s Disease demonstrates increased levels of ptau217 in CSF, changes that correlate with increased cerebral p‐tau depositions

The App NL‐F mouse model of Alzheimer’s Disease demonstrates reduced serum Aß42 levels and Aß42/Aß40 ratio, changes that correlate with CSF Aß levels and cerebral Aß42 plaque load

CSF Aβ42 and Aβ40 and their relation to brain soluble and insoluble Aβ in the 5xFAD mouse model of Alzheimer’s disease

Risk sharing in managed entry agreements—A review of the Swedish experience

Galectin-3 ablation does not affect infarct size or inflammatory cytokines after experimental stroke in 24-month-old female mice

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease

Reduced CSF Aβ42 and Aβ42/Aβ40 ratio during early cerebral amyloid deposition in the App NL‐F knock‐in mouse model of Alzheimer’s disease

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease

Model‐based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease

Current and future costs of obesity in Sweden

The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and <i>App</i><SUP>NL-F/NL-F</SUP> mice

Suchergebnisse filtern